研究実績

2018年

英文、原著論文

  1. Makino K, Nakagawa T, Ito E, Kasahara I, Murata T, Fujimura T, Fukuhara H, Homma Y. Oncological and peri-surgical outcomes of radical prostatectomy for non-metastatic prostate cancer with prostate-specific antigen level of 50 ng/mL or greater. Jpn J Clin Oncol. 2018 Apr 4. doi: 10.1093/jjco/hyy044. [Epub ahead of print]
  2. Akiyama Y, Niimi A, Nomiya A, Yamada Y, Nakagawa T, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y.
    Extent of Hunner lesions: The relationships with symptom severity and clinical parameters in Hunner type interstitial cystitis patients.
    Neurourol Urodyn. 2018 Apr;37(4):1441-1447.

和文、原著論文、総説他

  1. 木村将貴, 佐々木賢一, 遠藤圭織, 金谷淳志, 山田幸央, 宮嵜英世, 中川徹.LUTS・ED 合併症例におけるタダラフィル連日単独投与が生活の質に与える影響.泌尿器外科 2018年31(5), 1~8

2017年

英文、原著論文

  1. Nakagawa T, Taguchi S, Uemura Y, Kanatani A, Ikeda M, Matsumoto A, Yoshida K, Kawai T, Nagata M, Yamada D, Komemushi Y, Suzuki M, Enomoto Y, Nishimatsu H, Ishikawa A, Nagase Y, Kondo Y, Tanaka Y, Okaneya T, Hirano Y, Shinohara M, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y. Nomogram for predicting survival of post-cystectomy recurrent urothelial carcinoma of the bladder. Urol Oncol. 2017;35:457.e15-457.e21. doi: 10.1016/j.urolonc.2016.12.010.
  2. Nakagawa T, Komemushi Y, Kawai T, Otsuka M, Miyakawa J, Uemura Y, Kanatani A, Taguchi S, Naito A, Suzuki M, Nishimatsu H, Hirano Y, Tanaka Y, Matsumoto A, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y. Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study. World J Urol, 2017 Oct;35(10):1569-1575. doi: 10.1007/s00345-017-2032-6.
  3. Nakagawa T, Taguchi S, Kanatani A, Kawai T, Ikeda M, Urakami S, Matsumoto A, Komemushi Y, Miyakawa J, Yamada D, Suzuki M, Enomoto Y, Nishimatsu H, Kondo Y, Nagase Y, Hirano Y, Okaneya T, Tanaka Y, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y. Oncologic Outcome of Metastasectomy for Urothelial Carcinoma: Who is the Best Candidate? Ann Surg Oncol. 2017;24:2794-2800. doi: 10.1245/s10434-017-5970-8.
  4. Miyazaki H, Hirano Y, Kato S, Ioritani N, Ichikawa T, Takamoto H, Homma Y.
    Early Experiences of Contact Laser Vaporization of the Prostate using the 980 nm High Power Diode Laser for Benign Prostatic Hyperplasia Low Urin Tract Symptoms. 2017 Jun 2. doi: 10.1111/luts.12173.
  5. Kimura M, Nagao K, Tai T, Kobayashi H, Nakajima K.
    Age is a significant predictor of early and late improvement in semen parameters after microsurgical varicocele repair. Andrologia. 2017 Apr;49(3). doi: 10.1111/and.12620.
  6. Akiyama Y, Maeda D, Morikawa T, Niimi A, Nomiya A, Yamada Y, Igawa Y, Goto A, Fukayama M, Homma Y.
    Digital quantitative analysis of mast cell infiltration in interstitial cystitis.
    Neurourol Urodyn. 2017 Oct 24 doi: 10.1002/nau.23365.
  7. Matsumoto A, Nakagawa T, Kanatani A, Ikeda M, Kawai T, Miyakawa J, Taguchi, S, Naito A, Otsuka M, Nakanishi Y, Suzuki M, Koga F, Nagase Y, Kondo Y, Okaneya T, Tanaka Y, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y. Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer. World J Urol. 2018;36(2):249-56. doi: 10.1007/s00345-017-2141-2.

和文、原著論文、総説他

  1. 中川徹.高齢の尿路上皮癌患者治療における課題と戦略.泌尿器外科.30(臨時増刊号):687-9, 2017.
  2. 中川徹. <<日本臨床 増刊号 新腎・泌尿器癌(下)基礎・臨床研究の進歩>> 膀胱癌の検査・診断 取扱い規約とTNM分類. 日本臨床. 75(増刊号);118-22, 2017.
  3. 山田幸央中川徹. <<日本臨床 増刊号 新腎・泌尿器癌(下)基礎・臨床研究の進歩>> 膀胱癌の治療 尿道摘除術. 日本臨床. 75(増刊号);218-21, 2017.
  4. 宮嵜英世 デヴィータ がんの分子生物学 第2版 第16章 前立腺がんの分子生物学 日本語訳 305-319